Media Highlights
New algorithm can identify cells that humans can’t
January 11, 2021
Researchers at the University of British Columbia have developed an algorithm that can accurately identify different types of cells pictured in microscope photos, even when those cells are indistinguishable to the human eye.
The Kastrup Lab receives $2.3m USD to launch 2 new projects treating soldiers suffering from severe, uncontrolled bleeding
December 16, 2020
The funding will go towards improving platelet blood products and developing a wound dressing called CounterFlow Gauze, both of which are especially relevant to soldiers in combat scenarios.
November 2020: Notes from the CBR Director
November 19, 2020
Here we are now, almost 23 years since the Krever report, amidst another “unprecedented” public health disaster caused by yet another virus – arguably more menacing than the others, causing world-wide havoc at many levels. As always, in our roles in academia, CBR members are meeting the challenges head-on.
Science Literacy Week 2020: Meet the Blood Cells!
September 28, 2020
For Science Literacy Week 2020, we invited our audience to #MeetTheBloodCells on social media, from the Excellent Erythrocyte to the Noble Neutrophil.
Joining forces to improve blood research in Canada
September 24, 2020
Partnership with Canadian Blood Services and UBC’s Centre for Blood Research helps train the next generation of blood scientists.
Nobel Prize Series Introduction: Pomp and Circumstance?
August 27, 2020
Just like the Oscars (and basically every award), the Nobel Prize is not without its criticisms and controversies.
Fast and Furious: Targeting “nitro(gen) boosts” in a deadly bacterium for next-generation antimicrobials
August 20, 2020
What if bacteria also had the ability to use nitrogen for a “boost”? Alford et al. recently examined the role of a two-component system called NtrBC in Pseudomonas aeruginosa.
Identifying Patients At Risk of Severe Complications Using Sequencing Technology
July 9, 2020
Dr. Bob Hancock, UBC Killam professor, will use genomic methods to identify which patients with COVID-19 are at higher risk of developing life-threatening sepsis.
Anticoagulant RNA-Based Therapies For SARS-CoV-2 Related Thrombosis
July 2, 2020
SARS-CoV-2 leads to hyper-coagulability of blood and deadly blood clots (thrombosis).
Risk Management Frameworks For Workplace Safety
June 18, 2020
As Canada and other countries develop strategies for economic recovery and returning to business, the challenge each government and business faces will be how to develop solutions that can mitigate COVID-19 spread and the risks to a safe return to places of employment.